Ligand validation:4UIQ

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 4UIQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UIQ_HEM_B_200	92%	18%	0.09	0.98	1.83	1.72	5	8	1	0	100%	1
4UIQ_HEM_A_200	88%	12%	0.096	0.971	1.82	2.19	8	13	1	0	100%	0.9884
4UIQ_HEM_A_201	81%	16%	0.119	0.97	1.93	1.77	7	10	1	0	100%	0.5
4UIQ_HEM_B_201	15%	11%	0.307	0.866	1.97	2.21	7	11	3	0	100%	0.5
6M9A_HEM_A_200	84%	24%	0.122	0.983	1.53	1.59	6	10	0	0	100%	1
6I2Z_HEM_A_200	61%	23%	0.183	0.973	1.44	1.74	8	9	0	0	100%	1
5YCE_HEM_A_201	100%	37%	0.036	0.997	1.14	1.34	2	6	1	0	100%	1
1GWE_HEM_A_504	100%	43%	0.041	0.998	0.98	1.21	1	6	0	0	100%	1
3X34_HEM_A_101	100%	28%	0.043	0.997	1.33	1.54	8	12	2	0	100%	0.8972
1BZ6_HEM_A_154	100%	39%	0.044	0.995	1.19	1.21	3	4	0	0	100%	1
1PA2_HEM_A_306	100%	11%	0.044	0.995	1.65	2.54	9	16	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.